Related Experiment Video
Updated: Jul 8, 2025

Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
Tapentadol dependence through intravenous injection ('shooting') of crushed tablets associated with cutaneous
Vijaya Chandra Reddy Avula1, Sreeja S Vullanki2, Shashidhara Munivenkatappa1
1Psychiatry, All India Institute of Medical Sciences, Mangalagiri, India.
Abstract:
Tapentadol is a synthetic opioid analgesic with a low risk of abuse and diversion. The rising trend of abuse of tapentadol is largely attributable to its intrinsic pharmacological profile and easy availability due to poor regulatory control. We report a case of intravenous injection of crushed tapentadol tablets that presented with cutaneous adverse drug reactions. Cutaneous adverse reactions are common in injection drug abuse, and clinical examination is a must to inspect the injection sites. Stringent regulatory measures are required to restrict the increasing abuse of tapentadol in India.
More Related Videos
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Desensitization and Tachyphylaxis
Drug Dependence
Drug Abuse and Addiction: Pharmacological Phenomena
Parenteral Anesthetics: Overview

